Literature DB >> 26700710

Decreasing Irradiated Rat Lung Volume Changes Dose-Limiting Toxicity From Early to Late Effects.

Sonja J van der Veen1, Hette Faber1, Ghazaleh Ghobadi1, Sytze Brandenburg2, Johannes A Langendijk3, Robert P Coppes1, Peter van Luijk4.   

Abstract

PURPOSE: Technological developments in radiation therapy result in smaller irradiated volumes of normal tissue. Because the risk of radiation therapy-induced toxicity generally depends on irradiated volume, changing volume could change the dose-limiting toxicity of a treatment. Recently, in our rat model, we found that early radiation-induced lung dysfunction (RILD) was closely related to irradiated volume dependent vascular remodeling besides inflammation. The exact relationship between early and late RILD is still unknown. Therefore, in this preclinical study we investigated the dose-volume relationship of late RILD, assessed its dependence on early and late pathologies and studied if decreasing irradiated volume changed the dose-limiting toxicity. METHODS AND MATERIALS: A volume of 25%, 32%, 50%, 63%, 88%, or 100% of the rat lung was irradiated using protons. Until 26 weeks after irradiation, respiratory rates were measured. Macrovascular remodeling, pulmonary inflammation, and fibrosis were assessed at 26 weeks after irradiation. For all endpoints dose-volume response curves were made. These results were compared to our previously published early lung effects.
RESULTS: Early vascular remodeling and inflammation correlated significantly with early RILD. Late RILD correlated with inflammation and fibrosis, but not with vascular remodeling. In contrast to the early effects, late vascular remodeling, inflammation and fibrosis showed a primarily dose but not volume dependence. Comparison of respiratory rate increases early and late after irradiation for the different dose-distributions indicated that with decreasing irradiated volumes, the dose-limiting toxicity changed from early to late RILD.
CONCLUSIONS: In our rat model, different pathologies underlie early and late RILD with different dose-volume dependencies. Consequently, the dose-limiting toxicity changed from early to late dysfunction when the irradiated volume was reduced. In patients, early and late RILD are also due to different pathologies. As such, new radiation techniques reducing irradiated volume might change the dose-limiting toxicity of the radiation therapy treatment.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26700710     DOI: 10.1016/j.ijrobp.2015.09.034

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  Delayed Effects of Acute Radiation Exposure (Deare) in Juvenile and Old Rats: Mitigation by Lisinopril.

Authors:  Meetha Medhora; Feng Gao; Tracy Gasperetti; Jayashree Narayanan; Abdul Hye Khan; Elizabeth R Jacobs; Brian L Fish
Journal:  Health Phys       Date:  2019-04       Impact factor: 1.316

Review 2.  Pulmonary Function Changes After Radiotherapy for Lung or Esophageal Cancer: A Systematic Review Focusing on Dose-Volume Parameters.

Authors:  Anne G H Niezink; Renske A de Jong; Christina T Muijs; Johannes A Langendijk; Joachim Widder
Journal:  Oncologist       Date:  2017-05-26

3.  Enhanced pulmonary uptake on 18F-FES-PET/CT scans after irradiation of the thoracic area: related to fibrosis?

Authors:  C M Venema; E F J de Vries; S J van der Veen; M D Dorrius; M van Kruchten; C P Schröder; G A P Hospers; A W J M Glaudemans
Journal:  EJNMMI Res       Date:  2019-08-23       Impact factor: 3.138

4.  Regional and organ-level responses to local lung irradiation in sheep.

Authors:  David Collie; Steven H Wright; Jorge Del-Pozo; Elaine Kay; Tobias Schwarz; Magdalena Parys; Jessica Lawrence
Journal:  Sci Rep       Date:  2021-05-05       Impact factor: 4.379

5.  Image Based Data Mining Using Per-voxel Cox Regression.

Authors:  Andrew Green; Eliana Vasquez Osorio; Marianne C Aznar; Alan McWilliam; Marcel van Herk
Journal:  Front Oncol       Date:  2020-07-21       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.